Quest Diagnostics
$233.33Change from previous close: +0.97%Absolute change: +$2.24
At a glance
- Revenue growth
- +11.78%
- 2025 vs 2024
- Net income growth
- +13.89%
- 2025 vs 2024
- Net margin
- 9.0%
- 2024: 8.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 11,035 | 9,872 | 9,252 | 9,883 | — |
| Cost of revenue | 7,370 | 6,628 | 6,199 | 6,450 | — |
| Gross profit | 3,665 | 3,244 | 3,053 | 3,433 | — |
| Selling, general and administrative | 1,967 | 1,770 | 1,642 | 1,874 | — |
| Operating income | 1,556 | 1,346 | 1,262 | 1,428 | — |
| EBIT | 1,595 | 1,401 | 1,293 | 1,383 | — |
| EBITDA | 2,165 | 1,894 | 1,732 | 1,820 | — |
| Interest expense | 277 | 226 | 163 | 148 | — |
| Pre-tax income | 1,318 | 1,175 | 1,130 | 1,235 | — |
| Income tax | 314 | 273 | 248 | 264 | — |
| Net income | 992 | 871 | 854 | 946 | — |
| Net income to common shareholders | 988 | 866 | 850 | 942 | — |
| Basic EPS | 8.87 | 7.78 | 7.59 | 8.10 | — |
| Diluted EPS | 8.75 | 7.69 | 7.49 | 7.97 | — |
| Average shares (basic) | 111 | 111 | 112 | 116 | — |
| Average shares (diluted) | 113 | 113 | 113 | 118 | — |